ArticleBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2023

Assessment of Reported Adverse Events After Interchanging Between TNF-α Inhibitor Biosimilars in the WHO Pharmacovigilance Database.

Orhon Pauline et al.PubMed ↗Publisher ↗

No numbers read from the abstract.